Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin)
- Status
- COMPLETED
- Phase
- N/A
Local Ablative Strategies After Endovascular Radioembolization
- Status
- TERMINATED
- Phase
- PHASE1
Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy
- Status
- TERMINATED
- Phase
- NA
ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
LifePearl-Iri Pharmacokinetic Study
- Status
- COMPLETED
- Phase
- NA
Avastin (Bevacizumab) in the Treatment of Metastatic Colorectal Cancer in Normal Clinical Use in the UK Population
- Status
- WITHDRAWN
- Phase
- N/A
Abscopal Effect for Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP)
- Status
- TERMINATED
- Phase
- NA
Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino)
- Status
- UNKNOWN
- Phase
- PHASE2
Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1